HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jung-Hyun Shim Selected Research

Advanced Glycation End Products

1/2014Specificity protein 1 is a novel target of 2,4-bis (p-hydroxyphenyl)-2-butenal for the suppression of human oral squamous cell carcinoma cell growth.
1/20122,4-bis (p-hydroxyphenyl)-2-butenal (HPB242) induces apoptosis via modulating E7 expression and inhibition of PI3K/Akt pathway in SiHa human cervical cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jung-Hyun Shim Research Topics

Disease

66Neoplasms (Cancer)
11/2023 - 03/2004
16Squamous Cell Carcinoma of Head and Neck
01/2024 - 10/2013
14Colorectal Neoplasms (Colorectal Cancer)
01/2024 - 07/2009
12Lung Neoplasms (Lung Cancer)
07/2023 - 05/2010
9Esophageal Squamous Cell Carcinoma
01/2024 - 11/2019
9Mouth Neoplasms (Oral Cancer)
03/2023 - 01/2010
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2023 - 01/2015
8Malignant Mesothelioma
07/2016 - 05/2012
7Inflammation (Inflammations)
06/2024 - 06/2017
7Skin Neoplasms (Skin Cancer)
01/2024 - 04/2009
7Melanoma (Melanoma, Malignant)
01/2023 - 06/2015
6Carcinogenesis
05/2019 - 04/2009
5Neoplastic Cell Transformation
03/2017 - 01/2008
5Mesothelioma
06/2013 - 02/2012
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2020 - 01/2010
4Colonic Neoplasms (Colon Cancer)
08/2019 - 07/2009
4Breast Neoplasms (Breast Cancer)
12/2017 - 07/2010
4Leukemia
03/2015 - 10/2008
4Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2012 - 11/2005
3Obesity
10/2022 - 10/2008
3Esophageal Neoplasms (Esophageal Cancer)
06/2021 - 12/2019
3Hyperuricemia
12/2018 - 06/2017
2Hepatocellular Carcinoma (Hepatoma)
03/2023 - 02/2015
2Mitochondrial Diseases (Mitochondrial Disease)
03/2023 - 11/2021
2Alopecia (Baldness)
01/2023 - 12/2022
2Hyperlipidemias (Hyperlipidemia)
10/2022 - 01/2020
2Thymoma (Thymic Carcinoma)
09/2020 - 10/2017
2Neoplasm Metastasis (Metastasis)
06/2019 - 04/2016

Drug/Important Bio-Agent (IBA)

33Proteins (Proteins, Gene)FDA Link
07/2023 - 07/2009
12AntioxidantsIBA
06/2023 - 03/2008
11Phosphotransferases (Kinase)IBA
07/2023 - 10/2008
10p38 Mitogen-Activated Protein KinasesIBA
02/2023 - 07/2010
7Gefitinib (Iressa)FDA Link
07/2023 - 10/2019
7CaspasesIBA
07/2023 - 10/2008
7SurvivinIBA
01/2014 - 04/2011
6Reactive Oxygen Species (Oxygen Radicals)IBA
06/2023 - 02/2012
5Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2024 - 10/2022
5licochalcone BIBA
03/2023 - 04/2016
5Tyrosine Kinase InhibitorsIBA
03/2023 - 10/2019
5deoxypodophyllotoxinIBA
10/2022 - 05/2019
5Cyclin D1IBA
01/2014 - 05/2012
4Chalcone (Benzalacetophenone)IBA
01/2024 - 11/2022
4licochalcone CIBA
01/2024 - 12/2018
4licochalcone HIBA
11/2023 - 01/2019
4Epidermal Growth Factor (EGF)IBA
11/2023 - 10/2012
43-deoxysappanchalconeIBA
07/2023 - 08/2019
4ErbB Receptors (EGF Receptor)IBA
03/2023 - 10/2012
4Protein Kinases (Protein Kinase)IBA
01/2021 - 10/2017
4Annexin A5IBA
01/2020 - 12/2017
4Caspase 3 (Caspase-3)IBA
12/2019 - 04/2009
4esculetinIBA
01/2017 - 01/2015
3licochalcone DIBA
11/2023 - 01/2019
3PolyaminesIBA
06/2023 - 01/2016
3echinatinIBA
02/2023 - 11/2019
3Matrix Metalloproteinases (MMPs)IBA
11/2021 - 01/2020
3LignansIBA
11/2021 - 09/2020
3Podophyllotoxin (Condylox)FDA LinkGeneric
11/2021 - 06/2020
3Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2021 - 01/2020
3FlavonoidsIBA
01/2021 - 07/2012
3EnzymesIBA
12/2019 - 01/2010
3licochalcone AIBA
12/2017 - 08/2014
3Sp1 Transcription FactorIBA
01/2017 - 10/2012
3kahweolIBA
12/2016 - 06/2012
3coumarinIBA
05/2016 - 01/2015
3beta-lapachoneIBA
02/2016 - 01/2015
3Histones (Histone)IBA
01/2015 - 01/2008
3honokiolIBA
01/2015 - 06/2013
3epigallocatechin gallate (epigallocatechin-3-gallate)IBA
09/2011 - 10/2008
3tolfenamic acidIBA
04/2011 - 07/2010
2SpermidineIBA
06/2023 - 09/2021
2Therapeutic UsesIBA
02/2023 - 10/2017
2AndrogensIBA
01/2023 - 04/2011
2AntigensIBA
01/2023 - 01/2005
2Superoxides (Superoxide)IBA
11/2022 - 10/2020
2linderalactoneIBA
10/2022 - 10/2020
2Actin Depolymerizing Factors (Cofilins)IBA
01/2021 - 06/2019
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021 - 10/2008
2Propidium (Propidium Iodide)IBA
08/2019 - 01/2019
2DAPIIBA
01/2019 - 07/2013
2AgarIBA
01/2019 - 05/2018
2Ethanol (Ethyl Alcohol)IBA
12/2018 - 01/2018
2Xanthine OxidaseIBA
12/2018 - 01/2018
2herbacetinIBA
10/2017 - 01/2016
2Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA
10/2017 - 01/2016
2DiterpenesIBA
12/2016 - 06/2012
2manumycinIBA
07/2016 - 11/2015
2jugloneIBA
06/2015 - 07/2012
2Peptidylprolyl Isomerase (Prolyl Isomerase)IBA
06/2015 - 07/2010
2QuercetinIBA
02/2015 - 10/2012
2CoffeeFDA Link
12/2014 - 06/2012
22,4-bis(p-hydroxyphenyl)-2-butenalIBA
01/2014 - 01/2012
2FructoseIBA
01/2014 - 01/2012
2Tyrosine (L-Tyrosine)FDA Link
01/2014 - 01/2012
2Advanced Glycation End ProductsIBA
01/2014 - 01/2012
2ResveratrolIBA
01/2014 - 07/2012
2Messenger RNA (mRNA)IBA
05/2012 - 03/2011

Therapy/Procedure

18Therapeutics
01/2024 - 07/2009
5Oral Administration
06/2024 - 11/2011
3Drug Therapy (Chemotherapy)
02/2023 - 05/2020
3Immunotherapy
01/2021 - 11/2005